Literature DB >> 23204901

An unusual cause of chest pain: Acute coronary syndrome following administration of ergotamine tartrate.

Sercan Okutucu1, Ugur Nadir Karakulak, Giray Kabakcı, Kudret Aytemir.   

Abstract

For many years, ergotamine has been used for the acute treatment of migraine. Ergotamine may produce coronary vasospasm, which is often associated with ischemic electrocardiography changes and angina pectoris. A 62-year-old woman who was admitted to the emergency department because of chest pain is described. She had a history of severe migraine attacks and started to use ergotamine tartrate 0.75 mg daily the day before. Electrocardiography revealed sinus tachycardia with left anterior hemiblock and T wave inversion in the precordial leads. Cardiac biomarker levels were elevated. After discontinuation of the drug and initiation of vasodilator treatment, her chest pain resolved. Patients with migraine may have an underlying vasospastic disorder predisposing them to coronary artery spasm. Physicians should be alerted to potential cardiac vasospastic effects of low-dose ergotamine in the treatment of migraine.

Entities:  

Keywords:  Acute coronary syndrome; Ergotamine; Migraine

Year:  2012        PMID: 23204901      PMCID: PMC3383368     

Source DB:  PubMed          Journal:  Exp Clin Cardiol        ISSN: 1205-6626


  9 in total

Review 1.  Ergotamine, dihydroergotamine: current uses and problems.

Authors:  P Tfelt-Hansen
Journal:  Curr Med Res Opin       Date:  2001       Impact factor: 2.580

2.  Universal definition of acute myocardial infarction: the role of cardiac troponins and the need for sensitive and standardized assays.

Authors:  David C Gaze
Journal:  Curr Opin Investig Drugs       Date:  2008-03

3.  Prinzmetal's variant angina.

Authors:  T O Cheng
Journal:  J Cardiol       Date:  1998-06       Impact factor: 3.159

4.  Effects of ergotamine on myocardial blood flow in migraineurs without evidence of atherosclerotic coronary artery disease.

Authors:  T Gnecchi-Ruscone; R Lorenzoni; D Anderson; N Legg; D Tousoulis; P D Winter; A Crisp; P G Camici
Journal:  Am J Cardiol       Date:  1998-05-01       Impact factor: 2.778

5.  Acute coronary syndrome associated with myocardial bridging due to ergotamine treatment for migraine.

Authors:  Avi Shimony; Ayal Romem; Sharon Horowitz; Raphael Boehm; Jacob Horowitz
Journal:  Int J Cardiol       Date:  2006-08-02       Impact factor: 4.164

Review 6.  Myocardial ischemia related to ergot alkaloids: a case report and literature review.

Authors:  B S Galer; R B Lipton; S Solomon; L C Newman; E L Spierings
Journal:  Headache       Date:  1991-07       Impact factor: 5.887

7.  Acute myocardial infarction induced by ergotamine tartrate: possible role of coronary arterial spasm.

Authors:  H Yasue; S Omote; A Takizawa; M Nagao
Journal:  Angiology       Date:  1981-06       Impact factor: 3.619

8.  Coronary side-effect potential of current and prospective antimigraine drugs.

Authors:  A MaassenVanDenBrink; M Reekers; W A Bax; M D Ferrari; P R Saxena
Journal:  Circulation       Date:  1998-07-07       Impact factor: 29.690

9.  [Variant angina pectoris related to the treatment of migraine].

Authors:  J J Gómez Barrado; S Turégano Albarrán; J C García Rubira; R Hidalgo Urbano; M Rodríguez Revuelta; I Pérez Leal; J T García Martínez; M González López; J M Cruz Fernández
Journal:  Rev Esp Cardiol       Date:  1995-09       Impact factor: 4.753

  9 in total
  1 in total

1.  Letter to the editor.

Authors:  Andreas Y Andreou
Journal:  Exp Clin Cardiol       Date:  2012-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.